Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States

Journal of Perinatology

Volumn 31, Issue 2, 2011, Pages 112-117

  Nock, M L ^a,b   Johnson, E M ^b   Krugman, R R ^a   Di Fiore, J M ^a,b   Fitzgerald, S ^c   Sandhaus, L M ^b,c   Walsh, M C ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

G6PD deficiency; neonatal hyperbilirubinemia; screening test

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN JAUNDICE; NEWBORN SCREENING; PHOTOTHERAPY; RETROSPECTIVE STUDY; UNITED STATES;

BILIRUBIN; FETAL BLOOD; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PATIENT READMISSION; PHOTOTHERAPY; PILOT PROJECTS; PROGRAM EVALUATION; RISK FACTORS; UNITED STATES;

EID: 79551617124     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.69     Document Type: Article

References (21)

1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371: 64-74.
2. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Org 1989; 67: 601-611.
3. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 2008; 111(1): 16-24.
4. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175(6): 587-590.
5. Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92: 342-346.
6. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR et al Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650-662.
7. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics 2000; 106(6): 1478-1480.
8. Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol 2009; 29: S46-S52.
9. Bhutani VK, Johnson LH, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14.
10. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114(1): 297-316.
11. Beutler E. G6PD deficiency. Blood 1994; 84(11): 3613-3636.
12. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Heller GZ, Stevenson DK. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phophate dehydrogenase deficiency. J Pediatr 2006; 149: 83-88.
13. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36h. Clin Perinatol 1998; 25: 295-302.
14. Kaplan M, Leiter C, Hammerman C, Rudensky B. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the newborn period. Clin Chem 1997; 43: 1236-1237.
15. Ainoon O, Alawiyah A, Yu YH, Cheong SK, Hamidah NH, Boo NY et al Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partial-deficiency females. SoutheastAsian J Trop Med Public Health 2003; 34(2): 405-414.
16. Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbaum P et al Neonatal hyperbilirubinemia in glucose-6-phosphate deydrogenase-deficient hetero-zygotes. Pediatrics 1999; 104: 68-74.
17. Wong FL, Boo NY, Ainoon O, Wang MK. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinemia. Singapore MedJ 2009; 50(1): 62-67.
18. Raju TN. Epidemiology of late preterm (near-term) births. ClinPerinatol 2006; 33(4): 751-763.
19. Davidoff MJ, Dias T, Damus K, Russell R, Bettegowda VR, Dolan S et al. Changes in the gestational age distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002. Semin Perinatol 2006; 30(1): 8-15.
20. Kaplan M, Muraca M, Vreman HJ, Hammerman C, Vilei MT, Rubaltelli FF et al Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonatal Ed 2005; 90: F123-F127.
21. JCAHO. Revised guidance to help prevent kernicterus. Sentinal Event Alert 2004; (31): 1-2.